Envista Holdings Corporation (NVST)

Market Cap	4.56B
Revenue (ttm)	2.58B
Net Income (ttm)	216.80M
Shares Out	163.82M
EPS (ttm)	1.23
PE Ratio	22.63
Forward PE	13.63
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,538,336
Open	27.62
Previous Close	27.56
Day's Range	27.25 - 28.00
52-Week Range	27.25 - 43.29
Beta	1.42
Analysts	Buy
Price Target	45.00 (+61.7%)
Earnings Date	Nov 2, 2023

About NVST

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists, and periodontists; and brackets and wires, tubes and bands, archwires, clear ali...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Sep 18, 2019
• Employees: 12,700
• Stock Exchange: NYSE
• Ticker Symbol: NVST

Financial Performance

In 2022, NVST's revenue was $2.57 billion, an increase of 2.40% compared to the previous year's $2.51 billion. Earnings were $243.10 million, a decrease of -28.60%.

Analyst Forecast

According to 4 analysts, the average rating for NVST stock is "Buy." The 12-month stock price forecast is $45.0, which is an increase of 61.70% from the latest price.

Price Target

$45.0

(61.70% upside)

Analyst Consensus: Buy